172 related articles for article (PubMed ID: 31634414)
1. Gene Editing to Generate Versatile Human Pluripotent Stem Cell Reporter Lines for Analysis of Differentiation and Lineage Tracing.
Bao X; Adil MM; Muckom R; Zimmermann JA; Tran A; Suhy N; Xu Y; Sampayo RG; Clark DS; Schaffer DV
Stem Cells; 2019 Dec; 37(12):1556-1566. PubMed ID: 31634414
[TBL] [Abstract][Full Text] [Related]
2. A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease.
Hazelbaker DZ; Beccard A; Bara AM; Dabkowski N; Messana A; Mazzucato P; Lam D; Manning D; Eggan K; Barrett LE
Stem Cell Reports; 2017 Oct; 9(4):1315-1327. PubMed ID: 29020615
[TBL] [Abstract][Full Text] [Related]
3. Protocol for the Generation of Human Pluripotent Reporter Cell Lines Using CRISPR/Cas9.
Zhong A; Li M; Zhou T
STAR Protoc; 2020 Sep; 1(2):. PubMed ID: 33073252
[TBL] [Abstract][Full Text] [Related]
4. Developing CRISPR/Cas9-Mediated Fluorescent Reporter Human Pluripotent Stem-Cell Lines for High-Content Screening.
Vojnits K; Nakanishi M; Porras D; Kim Y; Feng Z; Golubeva D; Bhatia M
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458632
[TBL] [Abstract][Full Text] [Related]
5. MAGIK: A rapid and efficient method to create lineage-specific reporters in human pluripotent stem cells.
Haideri T; Lin J; Bao X; Lian XL
Stem Cell Reports; 2024 May; 19(5):744-757. PubMed ID: 38579711
[TBL] [Abstract][Full Text] [Related]
6. Protocol for genome-scale CRISPR screening in engineered lineage reporter hPSCs to study cell fate determination.
Zhou Z; Ma L; Zhang X
STAR Protoc; 2021 Jun; 2(2):100548. PubMed ID: 34095862
[No Abstract] [Full Text] [Related]
7. Fluorescent indicators for continuous and lineage-specific reporting of cell-cycle phases in human pluripotent stem cells.
Chang Y; Hellwarth PB; Randolph LN; Sun Y; Xing Y; Zhu W; Lian XL; Bao X
Biotechnol Bioeng; 2020 Jul; 117(7):2177-2186. PubMed ID: 32277708
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Protocols for CRISPR/Cas9-based Gene Editing in Human Pluripotent Stem Cells.
Santos DP; Kiskinis E; Eggan K; Merkle FT
Curr Protoc Stem Cell Biol; 2016 Aug; 38():5B.6.1-5B.6.60. PubMed ID: 27532820
[TBL] [Abstract][Full Text] [Related]
9. Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System.
Li S; Xue H; Wu J; Rao MS; Kim DH; Deng W; Liu Y
Stem Cells Dev; 2015 Dec; 24(24):2925-42. PubMed ID: 26414932
[TBL] [Abstract][Full Text] [Related]
10. Genome Editing in Human Pluripotent Stem Cells.
Carlson-Stevermer J; Saha K
Methods Mol Biol; 2017; 1590():165-174. PubMed ID: 28353269
[TBL] [Abstract][Full Text] [Related]
11. Precise and efficient scarless genome editing in stem cells using CORRECT.
Kwart D; Paquet D; Teo S; Tessier-Lavigne M
Nat Protoc; 2017 Feb; 12(2):329-354. PubMed ID: 28102837
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9-edited Pax6-GFP reporter system facilitates the generation of mouse neural progenitor cells during differentiation.
Li Y; Li X; Wang H; Gao Q; Zhang J; Zhang W; Zhang Z; Li L; Yu Y; Shuai L
J Genet Genomics; 2018 May; 45(5):277-280. PubMed ID: 29803732
[No Abstract] [Full Text] [Related]
13. Genome Editing of Lineage Determinants in Human Pluripotent Stem Cells Reveals Mechanisms of Pancreatic Development and Diabetes.
Zhu Z; Li QV; Lee K; Rosen BP; González F; Soh CL; Huangfu D
Cell Stem Cell; 2016 Jun; 18(6):755-768. PubMed ID: 27133796
[TBL] [Abstract][Full Text] [Related]
14. GAPTrap: A Simple Expression System for Pluripotent Stem Cells and Their Derivatives.
Kao T; Labonne T; Niclis JC; Chaurasia R; Lokmic Z; Qian E; Bruveris FF; Howden SE; Motazedian A; Schiesser JV; Costa M; Sourris K; Ng E; Anderson D; Giudice A; Farlie P; Cheung M; Lamande SR; Penington AJ; Parish CL; Thomson LH; Rafii A; Elliott DA; Elefanty AG; Stanley EG
Stem Cell Reports; 2016 Sep; 7(3):518-526. PubMed ID: 27594589
[TBL] [Abstract][Full Text] [Related]
15. Genetic and Chemical Screenings Identify HDAC3 as a Key Regulator in Hepatic Differentiation of Human Pluripotent Stem Cells.
Li S; Li M; Liu X; Yang Y; Wei Y; Chen Y; Qiu Y; Zhou T; Feng Z; Ma D; Fang J; Ying H; Wang H; Musunuru K; Shao Z; Zhao Y; Ding Q
Stem Cell Reports; 2018 Jul; 11(1):22-31. PubMed ID: 29861165
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish.
González F
Dev Dyn; 2016 Jul; 245(7):788-806. PubMed ID: 27145095
[TBL] [Abstract][Full Text] [Related]
17. Efficient scarless genome editing in human pluripotent stem cells.
Ikeda K; Uchida N; Nishimura T; White J; Martin RM; Nakauchi H; Sebastiano V; Weinberg KI; Porteus MH
Nat Methods; 2018 Dec; 15(12):1045-1047. PubMed ID: 30504872
[TBL] [Abstract][Full Text] [Related]
18. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
Yumlu S; Bashir S; Stumm J; Kühn R
Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
[TBL] [Abstract][Full Text] [Related]
19. Genome Engineering for Stem Cell Transplantation.
Argani H
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):31-37. PubMed ID: 30777520
[TBL] [Abstract][Full Text] [Related]
20. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus.
Merkle FT; Neuhausser WM; Santos D; Valen E; Gagnon JA; Maas K; Sandoe J; Schier AF; Eggan K
Cell Rep; 2015 May; 11(6):875-883. PubMed ID: 25937281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
